Physician profile
Edward Chen
NPI 1174561435
$1,612.33
in general payments reported to CMS, 2019-2025
20 companies · $346 in 2025
The $346 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $116 · 2021: $191 · 2022: $213 · 2023: $243 · 2024: $139 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.05 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $782.99 | 2019-2025 | Bridion, Keytruda |
| Mallinckrodt Enterprises LLC | $162.14 | 2019 | |
| Abbott Laboratories | $134.43 | 2025 | Proclaim |
| Comsort, INC | $100.00 | 2019 | |
| Aerin Medical INC. | $90.56 | 2025 | |
| Heron Therapeutics, INC. | $48.15 | 2021-2023 | Zynrelef |
| Nevro Corp. | $33.73 | 2022 | |
| Eagle Pharmaceuticals, INC. | $26.13 | 2023 | |
| Acelrx Pharmaceuticals, INC. | $22.84 | 2019 | |
| Trevena, INC. | $22.52 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.17 | 2024 | |
| Mallinckrodt Hospital Products INC. | $22.05 | 2020 | |
| Dendreon Pharmaceuticals LLC | $21.97 | 2019 | |
| Rayner Intraocular Lenses Limited | $21.86 | 2025 | Omidria |
| Sumitomo Pharma America, INC. | $21.25 | 2025 | Gemtesa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.55 | 2025 | |
| Ambu INC. | $17.45 | 2022 | |
| Myriad Genetic Laboratories, INC. | $17.07 | 2021 | |
| Baudax Bio INC. | $12.98 | 2020 | |
| Clarus Therapeutics INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.